{"transactions":[{"id":793858,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T21:28:00.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":11296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":11296,"derivative":{"exercise_price":7.99,"expiration_date":"2033-04-30","underlying":"Common Stock","underlying_shares":11296},"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":793857,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:00.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":1057,"price":8.97,"value":9481.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $8.79 to $8.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":79941,"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":793856,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:00.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":16145,"price":8.36,"value":134972.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on April 29, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price for sales executed on the same day within a one-dollar price range. These shares were sold in multiple transactions at prices ranging from $7.77 to $8.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":80998,"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":793855,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T21:28:00.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":25344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":97143,"source":{"system":"sec-edgar","filing":"0001685720-26-000003","document":"wk-form4_1777930077.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000168572026000003/wk-form4_1777930077.xml","form_type":"4"}},{"id":1063928,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-18T20:33:31.000Z","date":"2025-08-15","kind":"sale","planned":true,"acquired":false,"shares":7086,"price":8.87,"value":62852.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated May 16, 2025, for the purpose of satisfying tax obligations relating\nto the vesting of RSUs on May 22, 2025 and May 25, 2025, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All shares sold at an exact price of $8.87."}],"balance_after":71799,"source":{"system":"sec-edgar","filing":"0001628280-25-040670","document":"wk-form4_1755549206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000162828025040670/wk-form4_1755549206.xml","form_type":"4"}},{"id":1161189,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-03T00:31:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":15824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by multiplying 25% of the total non-employee director compensation value, and then dividing by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":41572,"derivative":{"exercise_price":5.45,"expiration_date":"2032-04-29","underlying":"Common Stock","underlying_shares":15824},"source":{"system":"sec-edgar","filing":"0001367644-25-000108","document":"wk-form4_1746232265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764425000108/wk-form4_1746232265.xml","form_type":"4"}},{"id":1161188,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-03T00:31:12.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":34403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":78885,"source":{"system":"sec-edgar","filing":"0001367644-25-000108","document":"wk-form4_1746232265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764425000108/wk-form4_1746232265.xml","form_type":"4"}},{"id":1209642,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T22:13:08.000Z","date":"2025-03-12","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":5.73,"value":57300.0,"ownership":{"direct":true},"balance_after":44482,"source":{"system":"sec-edgar","filing":"0001367644-25-000059","document":"wk-form4_1741817583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764425000059/wk-form4_1741817583.xml","form_type":"4"}},{"id":1488447,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:16:20.000Z","date":"2024-06-04","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":6.11,"value":61100.0,"ownership":{"direct":true},"balance_after":54482,"source":{"system":"sec-edgar","filing":"0001367644-24-000098","document":"wk-form4_1717704966.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764424000098/wk-form4_1717704966.xml","form_type":"4"}},{"id":1496699,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T19:02:45.000Z","date":"2024-05-29","kind":"sale","planned":false,"acquired":false,"shares":1830,"price":4.61,"value":8436.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a grandfathered trading plan adopted by Ms. Zoon on June 15, 2022."}],"balance_after":64482,"source":{"system":"sec-edgar","filing":"0001367644-24-000095","document":"wk-form4_1717182155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764424000095/wk-form4_1717182155.xml","form_type":"4"}},{"id":1500427,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T01:14:31.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":25748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant."}],"balance_after":25748,"derivative":{"exercise_price":5.02,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":25748},"source":{"system":"sec-edgar","filing":"0001367644-24-000077","document":"wk-form4_1716945262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764424000077/wk-form4_1716945262.xml","form_type":"4"}},{"id":1500426,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T01:14:31.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":17430,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the \"Company\") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date (\"Annual Grant Vesting Date\"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date."}],"balance_after":66312,"source":{"system":"sec-edgar","filing":"0001367644-24-000077","document":"wk-form4_1716945262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764424000077/wk-form4_1716945262.xml","form_type":"4"}},{"id":1503716,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-23T21:15:35.000Z","date":"2024-05-21","kind":"sale","planned":false,"acquired":false,"shares":1089,"price":5.78,"value":6294.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a grandfathered  trading plan adopted by Ms. Zoon on June 15, 2022."}],"balance_after":48882,"source":{"system":"sec-edgar","filing":"0001367644-24-000065","document":"wk-form4_1716498920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764424000065/wk-form4_1716498920.xml","form_type":"4"}},{"id":1824163,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-24T12:28:36.000Z","date":"2023-06-02","kind":"sale","planned":true,"acquired":false,"shares":1830,"price":8.35,"value":15280.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Zoon."}],"balance_after":49971,"source":{"system":"sec-edgar","filing":"0001367644-23-000137","document":"wk-form4_1690201708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764423000137/wk-form4_1690201708.xml","form_type":"4"}},{"id":1824162,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-24T12:28:36.000Z","date":"2023-05-25","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":8.38,"value":14246.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Zoon."}],"balance_after":51801,"source":{"system":"sec-edgar","filing":"0001367644-23-000137","document":"wk-form4_1690201708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764423000137/wk-form4_1690201708.xml","form_type":"4"}},{"id":1874889,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-30T23:09:56.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":33847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan, as amended and restated. These restricted stock units vest in one installment beginning on the day prior to the first anniversary of the date of grant assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":53501,"source":{"system":"sec-edgar","filing":"0001367644-23-000110","document":"wk-form4_1685488183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764423000110/wk-form4_1685488183.xml","form_type":"4"}},{"id":2234185,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T20:16:09.000Z","date":"2022-06-09","kind":"sale","acquired":false,"shares":1173,"price":31.52,"value":36972.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."}],"balance_after":19654,"source":{"system":"sec-edgar","filing":"0001367644-22-000101","document":"wf-form4_165515135039033.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764422000101/wf-form4_165515135039033.xml","form_type":"4"}},{"id":2251455,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-31T20:13:36.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":8446,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":20827,"source":{"system":"sec-edgar","filing":"0001367644-22-000088","document":"wf-form4_165402799025784.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764422000088/wf-form4_165402799025784.xml","form_type":"4"}},{"id":2256777,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-25T20:12:35.000Z","date":"2022-05-24","kind":"sale","acquired":false,"shares":1996,"price":35.53,"value":70917.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended."}],"balance_after":12381,"source":{"system":"sec-edgar","filing":"0001367644-22-000077","document":"wf-form4_165350953758392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764422000077/wf-form4_165350953758392.xml","form_type":"4"}},{"id":2693455,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T20:37:50.000Z","date":"2021-05-25","kind":"sale","acquired":false,"shares":3139,"price":56.48,"value":177290.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86."}],"balance_after":14377,"source":{"system":"sec-edgar","filing":"0001367644-21-000101","document":"wf-form4_162214773924582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764421000101/wf-form4_162214773924582.xml","form_type":"4"}},{"id":2699020,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-24T21:11:24.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":5027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":17516,"source":{"system":"sec-edgar","filing":"0001367644-21-000095","document":"wf-form4_162189066691622.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764421000095/wf-form4_162189066691622.xml","form_type":"4"}},{"id":3061979,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-11T20:43:44.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":1000,"price":130.27,"value":130270.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."}],"balance_after":12489,"source":{"system":"sec-edgar","filing":"0001367644-20-000128","document":"wf-form4_159717860987210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764420000128/wf-form4_159717860987210.xml","form_type":"4"}},{"id":3133834,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-27T21:07:28.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":4093,"price":85.1019,"value":348322.0767,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $84.14 to $86.28."}],"balance_after":13489,"source":{"system":"sec-edgar","filing":"0001367644-20-000084","document":"wf-form4_159061362728074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764420000084/wf-form4_159061362728074.xml","form_type":"4"}},{"id":3135234,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T13:16:26.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":2821,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":17582,"source":{"system":"sec-edgar","filing":"0001367644-20-000080","document":"wf-form4_159049896921710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764420000080/wf-form4_159049896921710.xml","form_type":"4"}},{"id":3149057,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-14T20:30:08.000Z","date":"2020-05-12","kind":"sale","acquired":false,"shares":1660,"price":85.2134,"value":141454.244,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated."}],"balance_after":14761,"source":{"system":"sec-edgar","filing":"0001367644-20-000065","document":"wf-form4_158948818627729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764420000065/wf-form4_158948818627729.xml","form_type":"4"}},{"id":3222766,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-06T21:39:22.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":991,"price":60.6493,"value":60103.4563,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average sale price. These shares were sold in multiple transactions ranging from $60.6301 to $60.6850."}],"balance_after":16421,"source":{"system":"sec-edgar","filing":"0001367644-20-000027","document":"wf-form4_158353074503870.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764420000027/wf-form4_158353074503870.xml","form_type":"4"}},{"id":3366071,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-19T21:11:24.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":1000,"price":54.314,"value":54314.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average sale price. These shares were sold in multiple transactions ranging from $54.24 to $54.34."}],"balance_after":17412,"source":{"system":"sec-edgar","filing":"0001367644-19-000063","document":"wf-form4_157419786844482.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764419000063/wf-form4_157419786844482.xml","form_type":"4"}},{"id":3374643,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-12T14:52:19.000Z","date":"2019-11-08","kind":"sale","acquired":false,"shares":3082,"price":54.1481,"value":166884.4442,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.69 to $54.72."}],"balance_after":18412,"source":{"system":"sec-edgar","filing":"0001367644-19-000061","document":"wf-form4_157357032406627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764419000061/wf-form4_157357032406627.xml","form_type":"4"}},{"id":3418596,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-10T21:44:28.000Z","date":"2019-09-09","kind":"sale","acquired":false,"shares":1509,"price":56.1246,"value":84692.0214,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":21494,"source":{"system":"sec-edgar","filing":"0001367644-19-000046","document":"wf-form4_156815185293314.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000136764419000046/wf-form4_156815185293314.xml","form_type":"4"}},{"id":3510357,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-29T00:18:56.000Z","date":"2019-05-28","kind":"sale","acquired":false,"shares":1376,"price":43.3884,"value":59702.4384,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.04 to $43.58, inclusive."}],"balance_after":23003,"source":{"system":"sec-edgar","filing":"0001567619-19-012278","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000156761919012278/doc1.xml","form_type":"4"}},{"id":3510356,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-29T00:18:56.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":5736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of: (i) the day prior to the first anniversary of the date of grant, or (ii) the day prior to annual shareholder meeting; assuming continued service with the company."}],"balance_after":24379,"source":{"system":"sec-edgar","filing":"0001567619-19-012278","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000156761919012278/doc1.xml","form_type":"4"}},{"id":3770640,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T23:49:05.000Z","date":"2018-11-07","kind":"sale","acquired":false,"shares":1871,"price":70.0789,"value":131117.6219,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.05 to $70.18, inclusive."}],"balance_after":18643,"source":{"system":"sec-edgar","filing":"0001567619-18-005458","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000156761918005458/doc1.xml","form_type":"4"}},{"id":3770639,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T23:49:05.000Z","date":"2018-11-07","kind":"sale","acquired":false,"shares":2371,"price":69.4804,"value":164738.0284,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.90 to $70.14, inclusive."}],"balance_after":20514,"source":{"system":"sec-edgar","filing":"0001567619-18-005458","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000156761918005458/doc1.xml","form_type":"4"}},{"id":3901746,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-07T20:20:06.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":376,"price":52.81,"value":19856.56,"ownership":{"direct":true},"balance_after":22885,"source":{"system":"sec-edgar","filing":"0001140361-18-027683","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000114036118027683/doc1.xml","form_type":"4"}},{"id":3915590,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T20:16:26.000Z","date":"2018-05-24","kind":"sale","acquired":false,"shares":1377,"price":51.15,"value":70433.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Zoon."}],"balance_after":23261,"source":{"system":"sec-edgar","filing":"0001140361-18-025992","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000114036118025992/doc1.xml","form_type":"4"}},{"id":3918826,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-24T20:34:40.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":4895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the day prior to the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":24638,"source":{"system":"sec-edgar","filing":"0001140361-18-025519","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000114036118025519/doc1.xml","form_type":"4"}},{"id":4165793,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T21:29:00.000Z","date":"2017-11-08","kind":"sale","acquired":false,"shares":371,"price":40.8446,"value":15153.3466,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest in three equal annual tranches beginning in November 2017."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.84 to $40.85, inclusive."}],"balance_after":19743,"source":{"system":"sec-edgar","filing":"0001140361-17-042137","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000114036117042137/doc1.xml","form_type":"4"}},{"id":4165792,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T21:29:00.000Z","date":"2017-11-08","kind":"sale","acquired":false,"shares":2371,"price":38.9443,"value":92336.9353,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Third Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest in three equal annual tranches beginning in November 2017."},{"field":"shares","element":"transactionShares","label":"F3","text":"The transactions reported in this row were effected pursuant to a Rule 10b5-1 plan adopted by Dr. Zoon."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.25, inclusive."}],"balance_after":20114,"source":{"system":"sec-edgar","filing":"0001140361-17-042137","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000114036117042137/doc1.xml","form_type":"4"}},{"id":4303124,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-26T18:13:31.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Fourth Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the earlier of (i) the anniversary of the date of grant or (ii) one business day prior to date of the Company's next annual meeting; provided that the individual is serving on the Board on such date."}],"balance_after":22485,"source":{"system":"sec-edgar","filing":"0001140361-17-022484","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000114036117022484/doc1.xml","form_type":"4"}},{"id":4560714,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":49959,"kind":"person","name":"Zoon Kathryn C","position":1,"cik":"0001685720","reported_name":"Zoon Kathryn C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-10T22:45:52.000Z","date":"2016-11-08","kind":"grant","acquired":true,"shares":14226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest in three equal annual tranches beginning in November 2017."}],"balance_after":14226,"source":{"system":"sec-edgar","filing":"0001140361-16-085896","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685720/000114036116085896/doc1.xml","form_type":"4"}}]}